A general health checkup assesses overall status and usually includes interview, measurements, blood pressure, urine and blood tests — about 8–15 items. A precision checkup is a detailed examination performed on an outpatient or short-stay basis and can include 100+ items. The key difference: it more easily detects cancer, heart disease and lifestyle diseases, providing a comprehensive assessment that helps find and address problems early.
| Dimension | Routine checkup | Precision checkup |
|---|---|---|
| Number of items | ~8–15 | 100+ |
| Setting | Standard outpatient | Outpatient or short-stay |
| Focus | Baseline health status | Early cancer, heart & lifestyle diseases |
| Methods | Interview / measurement / basic labs | Imaging + tumor markers + dedicated panels |
Screening uses imaging (e.g. mammography, colonoscopy) and lab tests (e.g. tumor markers) to detect cancer early. Early-stage cancer generally has higher treatment success, so regular screening can help reduce mortality risk.
A comprehensive assessment helps find and intervene on issues early, improving quality of life and healthy longevity. Those focused on early cancer and cardiovascular risk, with a family history, of advancing age, or in a long-term sub-health state usually benefit most. Suitability and the specific panel should be determined by a licensed physician.
Integrating premium global resources is AOSP's core advantage. Japan, for example, leads in minimally-invasive cancer therapy and imaging-based early screening. We partner with top institutions and experts to coordinate the institution, schedule, language and concierge support, and post-checkup health follow-up — making cross-border precision checkups convenient, deliverable and sustainable.
Routine covers ~8–15 items for baseline health; precision, on an outpatient/short-stay basis, includes 100+ items using imaging and labs to detect early cancer, heart and lifestyle diseases.
Cardiovascular, immune, liver/kidney function and blood markers, plus imaging panels for potential cancer, arteriosclerosis, cerebral infarctions, pancreatic/liver lesions and osteoporosis.
Those concerned about early cancer and cardiovascular risk, with family history, advancing age, or long-term sub-health. Suitability is determined by a licensed physician.
Japan leads in minimally-invasive cancer therapy and imaging-based screening, with mature programs. AOSP coordinates the institution, scheduling and follow-up.